Bet on Earnings, No...
Health Care: Health Services
CombiMatrix Corporation (CBMX: NASDAQ)
$2.95 0.41 | 16.14%
06/18/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.95 |
| 52 Week High | 14.14 |
| 52 Week Low | 1.40 |
| Avg. Daily Vol. (Mil) | 0.38 |
| Beta (3 year) | 0.13 |
| Share Related Items | |
| Mkt Cap (Mil) | 10.58 |
| Shares Out (Mil) | 3.59 |
| Float (Mil) | 3.07 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.09 |
| Total Debt / Equity | 0.20 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.86 |
| Price/Book | 5.08 |
| Price/Cash Flow | -1.40 |
| Per Share Data | |
| Earnings | -6.76 |
| Sales | 1.59 |
| Book Value | 0.58 |
| Cash Flow | -2.18 |
| Business Summary | |
|---|---|
| CombiMatrix Corporation is a molecular diagnostics company that operates mainly in the field of genetic analysis and molecular diagnostics. | |
| General Information | |
| 310 Goddard
Sute 150 Irvine, CA 92618 |
|
| www.combimatrix.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 41 | |
| CEO: Mark D. McDonough | |
| Short Interest | |
| Current Month (Mil) | 0.48 |
| Previous Month (Mil) | 0.52 |
| Short Interest Ratio (Days) | 1.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -112.50 |
| Return on Investments | -317.00 |
| Profitability | |
| Gross Margin | 57.10 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CBMX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- Userearn50kin365
- UserLivingstonGroup Portfolio -...
- UserHCH Portfolio
Latest CBMX Headlines from TheStreet
- Six Months After Publication Of Key Studies, CombiMatrix Sees Growth In Prenatal Testing Adoption 06.18.13 | 06:06 am
- CombiMatrix Corporation Reports Results For 2013 First Quarter 05.08.13 | 06:05 am
- CombiMatrix Executes Equity Financing 05.06.13 | 06:05 am
- CombiMatrix Corporation To Release First Quarter Financial Results On May 8, 2013 05.01.13 | 06:05 am
- 5 Health Care Stocks Under $10 Ready to Rip Higher 04.18.13 | 09:04 pm
- 5 Stocks Under $10 Set to Soar 04.04.13 | 01:04 pm
- CombiMatrix Reports Preliminary Quarterly Growth In Prenatal Testing Volumes Of 124% For First Quarter 04.04.13 | 06:04 am
- 5 Stocks Under $10 Set to Soar 03.28.13 | 01:03 pm
- 4 Stocks Under $10 Making Big Moves 03.26.13 | 02:03 pm
- CombiMatrix Announces $2 Million Registered Direct Offering 03.20.13 | 09:03 am
Press Releases for CBMX
- CombiMatrix Corporation Selects Cartagenia BENCHlab CNV Platform To Bolster Expanded Lab Operations - PR Newswire 11.01.12 | 10:11 am
Partner Headlines for CBMX
- Morning Market Losers - Benzinga 07.03.12 | 09:07 am
- China to Launch Own Iron Ore Platform in December - NASDAQ 11.24.11 | 06:11 am
- Initiating Affymetrix at Neutral - Analyst Blog - Zacks 04.15.11 | 06:04 pm
- UPDATE 1-CombiMatrix names new chief executive - Reuters 08.16.10 | 07:08 am
- UPDATE 2-CombiMatrix says to stop efforts to sell co, assets - Reuters 06.01.10 | 11:06 am
- UPDATE 1-CombiMatrix to restructure, CEO to step down - Reuters 04.19.10 | 04:04 pm
